Predictive Molecular Blood Biomarkers in Non-Small Cell Lung Cancer Publisher



Talischi MH¹ ; Mohamadnia A^{2, 3} ; Mahmoodi M¹ ; Bahrami N^{4, 5} ; Nasab AF⁶
Source: Journal of Cellular and Molecular Anesthesia Published:2022

Abstract

Background: Lung cancer is characterized by the uncontrolled growth of cells in the lung tissue. The purpose of the present study was to investigate the expression of MUC1 mRNA and CK19 mRNA biomarkers in patients with non-small-cell lung carcinoma (NSCLC). Materials and Methods: In this case-control research, thirty samples of cancer blood, thirty samples of cancer tissue, and the same number of healthy samples were prepared. Samples were collected and RNA was extracted, then cDNA was made and gene expression was measured using Real-Time PCR. Results: Among non-small-cell lung carcinoma patients, the MUC1 mRNA marker was positive for 19 individuals while in the healthy group, it was reported positive in 5 out of 30 individuals. In the patients' group, the CK19 mRNA marker was positive for 16 individuals while in the healthy group, in 6 out of 30 individuals. Conclusion: The MUC1 mRNA and CK19 mRNA as lung cancer tumor markers were reliable and sensitive; however, further studies are recommended. © 2022 Lavoisier. All rights reserved.